Oluwaseun O Akinduro1, Diogo P Garcia1, Ricardo A Domingo1, Tito Vivas-Buitrago1, Bernardo Sousa-Pinto2,3, Mohamad Bydon4, Michelle J Clarke4, Ziya L Gokaslan5, Maziyar A Kalani1, Kingsley Abode-Iyamah1, Alfredo Quiñones-Hinojosa6,7. 1. Department of Neurosurgery, Mayo Clinic, Jacksonville, FL, USA. 2. MEDCIDS - Department of Community Medicine, Information and Health Decision Sciences, Faculty of Medicine, University of Porto, Porto, Portugal. 3. CINTESIS - Center for Health Technology and Services Research, University of Porto, Porto, Portugal. 4. Department of Neurosurgery, Mayo Clinic, Rochester, MN, USA. 5. Department of Neurosurgery, Warren Alpert Medical School of Brown University, Providence, RI, USA. 6. Department of Neurosurgery, Mayo Clinic, Jacksonville, FL, USA. quinones@mayo.edu. 7. Brain Tumor Stem Cell Laboratory, Department of Neurologic Surgery, Mayo Clinic, 4500 San Pablo Rd. S, Jacksonville, FL, 32224, USA. quinones@mayo.edu.
Abstract
BACKGROUND: En bloc spondylectomy is the gold standard for surgical resection of sacral chordomas (CHO), but the effect of extent of resection on recurrence and survival in patients with CHO of the cervical spine remains elusive. METHODS: MEDLINE, Embase, Scopus, and Cochrane were systematically reviewed. Patients with cervical CHO treated at three tertiary-care academic institutions were reviewed for inclusion. We performed an individual participant data meta-analysis to assess the overall survival (OS) and progression free survival (PFS) after en bloc-gross total resection (GTR) and intralesional-GTR compared to subtotal resection (STR). We then performed an intention-to-treat analysis including all patients with attempted en bloc resection in the en bloc group, regardless of the surgical margins. RESULTS: There was a total of 13 series including 161 patients with cervical CHO, including our current series of 22 patients. GTR (en bloc-GTR + intralesional-GTR) was associated with a significant decrease in the risk of local progression (pooled hazard ratio (PHR) = 0.22; 95% CI 0.08-0.59; p = 0.003) and risk of death (PHR 0.31; 95%; CI 0.12-0.83; p = 0.020). A meta-regression analyses determined that intralesional-GTR improved PFS (PHR 0.35; 95% CI 0.16-0.76; p = 0.009) as well as OS (PHR 0.25; 95% CI 0.08-0.79; p = 0.019) when compared to STR. En bloc-GTR was associated with a significant reduction in the risk of local progression (PHR 0.06; 95% CI 0.01-0.77; p = 0.030), but not a decreased OS (PHR 0.50; 95% CI 0.19-1.27; p = 0.145). Our intention-to-treat analyses revealed a near significant improvement in OS for the en bloc group (PHR: 0.15; 95% CI 0.02-1.22; p = 0.054), and nearly identical improvement in PFS. Radiation data was not available for the studies included in the meta-analysis. CONCLUSION: This is the first and only meta-analysis of patients with cervical CHO. We found that both en bloc-GTR and intralesional-GTR resulted in improved local tumor control when compared to STR.
BACKGROUND: En bloc spondylectomy is the gold standard for surgical resection of sacral chordomas (CHO), but the effect of extent of resection on recurrence and survival in patients with CHO of the cervical spine remains elusive. METHODS: MEDLINE, Embase, Scopus, and Cochrane were systematically reviewed. Patients with cervical CHO treated at three tertiary-care academic institutions were reviewed for inclusion. We performed an individual participant data meta-analysis to assess the overall survival (OS) and progression free survival (PFS) after en bloc-gross total resection (GTR) and intralesional-GTR compared to subtotal resection (STR). We then performed an intention-to-treat analysis including all patients with attempted en bloc resection in the en bloc group, regardless of the surgical margins. RESULTS: There was a total of 13 series including 161 patients with cervical CHO, including our current series of 22 patients. GTR (en bloc-GTR + intralesional-GTR) was associated with a significant decrease in the risk of local progression (pooled hazard ratio (PHR) = 0.22; 95% CI 0.08-0.59; p = 0.003) and risk of death (PHR 0.31; 95%; CI 0.12-0.83; p = 0.020). A meta-regression analyses determined that intralesional-GTR improved PFS (PHR 0.35; 95% CI 0.16-0.76; p = 0.009) as well as OS (PHR 0.25; 95% CI 0.08-0.79; p = 0.019) when compared to STR. En bloc-GTR was associated with a significant reduction in the risk of local progression (PHR 0.06; 95% CI 0.01-0.77; p = 0.030), but not a decreased OS (PHR 0.50; 95% CI 0.19-1.27; p = 0.145). Our intention-to-treat analyses revealed a near significant improvement in OS for the en bloc group (PHR: 0.15; 95% CI 0.02-1.22; p = 0.054), and nearly identical improvement in PFS. Radiation data was not available for the studies included in the meta-analysis. CONCLUSION: This is the first and only meta-analysis of patients with cervical CHO. We found that both en bloc-GTR and intralesional-GTR resulted in improved local tumor control when compared to STR.
Entities:
Keywords:
Cervical spine; Chordoma; En bloc spondylectomy; Gross total resection; Subtotal resection
Authors: Ronny L Rotondo; Wendy Folkert; Norbert J Liebsch; Yen-Lin E Chen; Frank X Pedlow; Joseph H Schwab; Andrew E Rosenberg; G Petur Nielsen; Jackie Szymonifka; Al E Ferreira; Francis J Hornicek; Thomas F DeLaney Journal: J Neurosurg Spine Date: 2015-09-04
Authors: Chunzi Jenny Jin; John Berry-Candelario; Anne S Reiner; Ilya Laufer; Daniel S Higginson; Adam M Schmitt; Eric Lis; Ori Barzilai; Patrick Boland; Yoshiya Yamada; Mark H Bilsky Journal: J Neurosurg Spine Date: 2019-10-18
Authors: Gregory M Cote; Constance M Barysauskas; Thomas F DeLaney; Joseph Schwab; Kevin Raskin; Santiago Lozano-Calderon; Karen Bernstein; John T Mullen; Alex B Haynes; Francis Hornicek; Yen-Lin E Chen; Edwin Choy Journal: Int J Radiat Oncol Biol Phys Date: 2018-08-03 Impact factor: 7.038
Authors: Oluwaseun O Akinduro; Gaetano De Biase; Anshit Goyal; Jenna H Meyer; Sukhwinder J S Sandhu; Roman O Kowalchuk; Daniel M Trifiletti; Jason Sheehan; Kenneth W Merrell; Sujay A Vora; Daniel F Broderick; Michelle J Clarke; Mohamad Bydon; Jamal McClendon; Maziyar A Kalani; Alfredo Quiñones-Hinojosa; Kingsley Abode-Iyamah Journal: J Neurooncol Date: 2022-01-07 Impact factor: 4.130